new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Genentech Inc
Genentech Inc_20100107
Genentech Inc_20100114
Genentech Inc_20100128
Genentech Inc_20131212
Genentech Inc_20100121
  

Genentech Inc patents

Recent patent applications related to Genentech Inc. Genentech Inc is listed as an Agent/Assignee. Note: Genentech Inc may have other listings under different names/spellings. We're not affiliated with Genentech Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Genentech Inc-related inventors




Date Genentech Inc patents (updated weekly) - BOOKMARK this page
05/25/17 new patent  Methods of treating cancer using tigit inhibitors and anti-cancer agents
05/25/17 new patent  Anti-angiogenesis therapy for the treatment of ovarian cancer
05/25/17 new patent  Anti-factor d antibody variant conjugates and uses thereof
05/25/17 new patent  5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereof
05/25/17 new patent  Alkynyl alcohols and methods of use
05/25/17 new patent  Novel compositions and methods for the treatment of immune related diseases
05/25/17 new patent  Anti-factor d antibodies and conjugates
05/25/17 new patent  Anti-htra1 antibodies and methods of use thereof
05/25/17 new patent  Process for producing optically active 2-alkyl-1,1,3-trialkoxycarbonylpropane
05/18/17Combinations of anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
05/18/17Inhibitors of iap
05/18/17Aryl sultam derivatives as rorc modulators
05/18/17Pilr alpha interactions and methods of modifying same
05/18/17Anti-jagged1 antibodies and methods of use
05/18/17Anti-factor d antibody formulations
05/11/17Tetrahydronaphthalene estrogen receptor modulators and uses thereof
05/11/17Cystine knot scaffold platform
05/11/17Compositions and methods for the diagnosis and treatment of tumor
05/04/17Immuno-pet imaging of antibodies and immunoconjugates and uses therefor
05/04/17Methods of measuring factor d activity and potency of factor d inhibitors
04/27/17Ph adjustment to improve thaw recovery of cell banks
04/27/17Hindered disulfide drug conjugates
04/27/17Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors
04/27/17Influenza a h7n9 virus therapies
04/20/17Methods and compositions for modulating hgf/met
04/20/17Methods of treatment using anti-erbb antibody maytansinoid conjugates
04/20/17Calicheamicin-antibody-drug conjugates and methods of use
04/20/17Methods of using anti-pd-l1 antibodies and their use to enhance t-cell function to treat tumor immunity
04/13/17Anti-angiogenesis therapy for the treatment of breast cancer
04/13/17Process for the preparation of (e)-3-(4-((e)-2-(2-chloro-4-fluorophenyl)-1-(1h-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid
04/13/17Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
04/06/17Pyrrolobenzodiazepine antibody drug conjugates and methods of use
04/06/17Optimized variants of anti-vegf antibodies
04/06/17Antibody variants
03/30/17Substituted benzamides and methods of use thereof
03/30/173-substituted pyrazoles and uses thereof
03/30/17Macrocyclic broad spectrum antibiotics
03/30/17Il-22 polypeptides and il-22 fc fusion proteins and methods of use
03/30/17Anti-tigit antibodies and methods of use
03/30/17Biologically active c-terminal arginine-containing peptides
03/30/17Antibody selection apparatus and methods
03/23/17Benzoxazepin pi3k inhibitor compounds and methods of use
03/16/17Anti-vegf antibodies
03/16/17Il-17a/f heterologous polypeptides and therapeutic uses thereof
03/16/17Compositions and methods for the diagnosis and treatment of tumor
03/16/17Gene expression markers of tumor resistance to her2 inhibitor treatment
03/09/17Biomarkers for predicting sensitivity to cancer treatments
03/09/17Anti-ngf antibodies for the treatment of various disorders
03/09/17Methods of diagnosing and treating eosinophilic disorders
03/09/17Gram-positive bacteria specific binding compounds
03/02/17Anti-cd79b antibodies and immunoconjugates and methods of use
03/02/17Anti-ly6e antibodies and methods of use
03/02/17Methods and compositions for neural disease immunotherapy
02/23/17High concentration antibody and protein formulations
02/23/17Cell culture media and methods of antibody production
02/23/17Diagnostic methods and compositions for treatment of glioblastoma
02/23/17Biomarkers and methods of treating pd-1 and pd-l1 related conditions
02/16/17Treatment of complement-associated disorders
02/16/17Methods of using anti-steap1 antibodies and immunoconjugates
02/16/17Mutant smoothened and methods of using the same
02/16/17Methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors
02/16/17Humanized anti-beta7 antagonists and uses therefor
02/09/17Methods of treating early breast cancer with trastuzumab-mcc-dm1 and pertuzumab
02/09/17Methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors
02/09/17Fixed dosing of her antibodies
Patent Packs
02/02/17Anti-ephrinb2 antibodies and methods using same
02/02/17Compositions and methods for use in organ transplantation
02/02/17Methods for treating progressive multiple sclerosis
02/02/17Treatment of metastic breast cancer
02/02/17Methods and compositions for secretion of heterologous polypeptides
01/26/17Process for the manufacturing of medicaments
01/19/17Pyridyl inhibitors of hedgehog signalling
01/19/17Benzoxazepin oxazolidinone compounds and methods of use
01/19/17Combination therapy comprising anti-angiogenesis agents and ox40 binding agonists
01/12/17Bicyclic lactams and methods of use thereof
01/12/17Il-22 polypeptides and il-22 fc fusion proteins and methods of use
01/12/17Methods of treating her2-positive cancers using pd-1 axis binding antagonists and anti-her2 antibodies
01/12/17Methods of preparing a poloxamer for use in cell culture medium
01/05/17Compositions and methods of obtaining and using endoderm and hepatocyte cells
01/05/17Methods of treating cancer using anti-ox40 antibodies and pd-1 axis binding antagonists
Patent Packs
01/05/17Piperidine-dione derivatives
01/05/17Oxepan-2-yl-pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
01/05/17N-substituted benzamides and methods of use thereof
01/05/17Benzoxazepin oxazolidinone compounds and methods of use
01/05/17Anti-cd33 antibodies and immunoconjugates
01/05/17Methods of using anti-lgr5 antibodies
01/05/17Antibodies and immunoconjugates
12/29/16Methods of treatment with taselisib
12/29/16Anti-tau antibodies and methods of use
12/29/16Protein purification
12/22/16Azetidine estrogen receptor modulators and uses thereof
12/22/16Reduced-viscosity concentrated protein formulations
12/22/16Humanized and affinity matured antibodies to fcrh5 and methods of use
12/22/16Anti-cll-1 antibodies and methods of use
12/22/16Immunoglobulin variants with altered binding to protein a
12/22/16Ultrapurified dsba and dsbc and methods of making and using the same
12/08/161-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
12/08/16Polycyclic estrogen receptor modulators and uses thereof
12/08/16Methods and compositions for targeting polyubiquitin
12/08/16Methods of treating cancer using anti-ox40 antibodies
12/08/16Anti-pcsk9 antibodies, formulations, dosing, and methods of use
12/01/16Compositions and methods of treating lupus nephritis
12/01/16Heterocyclic estrogen receptor modulators and uses thereof
11/24/16Substituted benzamides and methods of use thereof
11/17/16Triazolopyridine jak inhibitor compounds and methods
11/17/16Methods for viral inactivation using eco-friendly detergents
11/17/16Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
11/10/16Versatile syringe platform
11/10/16Pyrazole carboxamide compounds, compositions and methods of use
11/10/16Inhibition of il-17 production
Social Network Patent Pack
11/03/16Use of cbp/ep300 bromodomain inhibitors for cancer immunotherapy
11/03/16Process for making hydroxylated cyclopentylpyrimidine compounds
11/03/16Methods and compositions comprising purified recombinant polypeptides
11/03/16Anti-pdl1 antibody formulations
11/03/16Antibodies and methods of use
11/03/16Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products
10/27/16Peptidomimetic compounds and antibody-drug conjugates thereof
10/27/16Treatment with anti-vegf antibodies
10/27/16Heteroaryl sultam derivatives as rorc modulators
10/27/16Mutant smoothened and methods of using the same
Patent Packs
10/20/16Serine/threonine kinase inhibitors
10/20/16Combination therapy with c-met and egfr antagonists
10/20/16Estrogen receptor modulators and uses thereof
10/20/16Serine/threonine kinase inhibitors
10/20/16Peptide inhibitors of bace1
10/20/16Anti-polyubiquitin antibodies
10/20/16Treatment with anti-vegf antibodies
10/20/16Neuropilin antagonists
10/20/16Bioreactors with multiple or adjustable-position agitator designs
10/13/16Aminoquinazoline and pyridopyrimidine derivatives
10/13/16Compositions and methods for the diagnosis and treatment of tumor
10/13/16N-substituted benzamides and methods of use thereof
10/13/16Estrogen receptor modulators and uses thereof
10/13/16Processes for the preparation of pyrimidinylcyclopentane compounds
09/29/16Combinations of a phosphoinositide 3-kinase inhibitor compound and a cdk4/6 inhibitor compound for the treatment of cancer
09/29/16Modulation of axon degeneration
09/29/16Anti-angiogenesis therapy for the treatment of ovarian cancer
09/29/16Peptidomimetic compounds and antibody-drug conjugates thereof
09/29/16Peptidomimetic compounds and antibody-drug conjugates thereof
09/22/16Usp7 inhibitor compounds and methods of use
09/22/16Keto-imidazopyridine derivatives as rorc modulators
09/22/16Humanized antibody
09/22/16Prevention and treatment of complement-associated eye conditions
09/22/16Methods for treating, diagnosing, and monitoring lupus
09/22/16Compositions and methods for prostate cancer analysis
09/15/16Substituted sulfonamide compounds
09/15/16Inhibitors of complement activation
09/15/16Biological markers and methods for predicting response to b-cell antagonists
09/08/16Azaindazole compounds as inhibitors of t790m containing egfr mutants
09/08/16Anti-vegf antibodies
Patent Packs
09/08/16Dual specific antibodies
09/08/16Methods of treating cancers using pd-1 axis binding antagonists and taxanes
09/01/16Methods of treating and preventing cancer drug resistance
09/01/16Deuterated compounds and uses thereof
09/01/16Crystalline forms of a pyrrolopyridine compound
09/01/16Antibody formulation
08/25/16Anti-angiogenesis therapy for the treatment of breast cancer
08/25/16Pyrazolopyrimidine jak inhibitor compounds and methods
08/25/16Humanized antibody
08/25/16Anti-fgfr2/3 antibodies and methods using same
08/18/16Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
08/18/165-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereof
08/18/16Anti-fgfr4 antibodies and methods of use
08/18/16Systems and methods for two-dimensional chromatography
08/11/16Heteroaryl pyridone and aza-pyrodine compounds
08/11/16Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use
08/11/16Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis
08/04/16Substituted heterocyclic sulfonamide compounds useful as trpa1 modulators
08/04/16Polymorphs of 2-(4-(2-(1-isopropyl-3-methyl-1h-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1h-pyrazol-1-yl)-2-methylpropanamide, methods of production, and pharmaceutical uses thereof
08/04/16Thiazolopyrimidinones and methods of use thereof
Social Network Patent Pack
08/04/16Gram-positive bacteria specific binding compounds
08/04/16Monovalent antibody fragments useful as therapeutics
08/04/16Nucleic acid encoding anti-pd-l1 antibodies
08/04/16Biomarkers and methods of treating pd-1 and pd-l1 related conditions
07/28/16Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
07/28/16Nsp4 inhibitors and methods of use
07/21/16Anti-il-4 antibodies and bispecific antibodies and uses thereof
07/21/16Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
07/14/16Modulation of axon degeneration
07/14/16Compositions and methods for stabilizing protein-containing formulations
07/14/16Anti-ly6e antibodies and immunoconjugates and methods of use
07/14/16Process for preparing a compound
07/14/16Alkynyl alcohols and methods of use
07/14/16Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b
06/30/16Anti-lrp5 antibodies and methods of use
06/30/16Triazolopyridine compounds, compositions and methods of use thereof
06/30/16Alkynyl alcohols and methods of use
06/30/16Methods of treating fgfr3 related conditions
06/30/16Serum albumin binding peptides for tumor targeting
06/30/16Methods and compositions for preventing norleucine misincorporation into proteins
Social Network Patent Pack
06/23/16Estrogen receptor modulators and uses thereof
06/23/16Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
06/23/16Treatment of pemphigus
06/23/16Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab
06/23/16Method for treating joint damage
06/23/16High-concentration monoclonal antibody formulations
06/23/16Methods for diagnosing and treating inflammatory bowel disease
06/16/16Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
06/16/16Subcutaneous anti-her2 antibody formulations and uses thereof
06/16/16Aryl sultam derivatives as rorc modulators
06/16/16Anti-hemagglutinin antibodies and methods of use
06/16/16Gram-positive bacteria specific binding compounds
06/16/16Humanized antibody igg1
06/16/16Anti-interleukin-33 antibodies and uses thereof
06/16/16Anti-fgfr3 antibodies and methods using same
06/16/16Immuno-pet imaging of antibodies and immunoconjugates and uses therefor
06/16/16Therapeutic and diagnostic methods for il-33-mediated disorders
06/09/16Therapeutic compounds and uses thereof
06/09/16Biheteroaryl compounds and uses thereof
06/09/16Methods and compositions for treating cancer using pd-1 axis antagonists and hpk1 antagonists
06/09/16Model of colorectal cancer
06/09/16Pyrazolo[3,4-c]pyridine compounds and methods of use
06/09/16Methods of producing two chain proteins in bacteria
06/09/16Methods of producing two chain proteins in bacteria
06/09/16Anti-cd79b antibodies and methods of use
06/09/16Anti-b7-h4 antibodies and immunoconjugates
06/09/16Methods of treating cancer and preventing cancer drug resistance
06/09/16Methods and biomarkers for predicting efficacy and evaluation of an ox40 agonist treatment
06/09/16Elucidation of ion exchange chromatography input optimization
06/09/16Modulation of axon degeneration
Social Network Patent Pack
06/09/16Assays for detecting t cell immune subsets and methods of use thereof
06/02/16Pyridyl inhibitors of hedgehog signalling
06/02/16Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
06/02/16Amorphous form of an akt inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof
06/02/16Pyrimidyl cyclopentanes as akt protein kinase inhibitors
06/02/16Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
06/02/16Pharmaceutical compounds
06/02/16Combination therapy comprising ox40 binding agonists and tigit inhibitors
06/02/16Methods and compositions for detecting and treating drug resistant akt mutant
05/26/16Methods of treating cancer and preventing cancer drug resistance
05/26/16Humanized anti-factor d antibodies and uses thereof
05/19/16Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
05/19/16Refolding of recombinant proteins
05/19/16Antibody formulations
05/19/16Highly concentrated pharmaceutical formulations
05/12/16Cysteine engineered antibodies and conjugates
05/12/16Harvest operations for recombinant proteins
05/05/16Serine/threonine kinase inhibitors
04/21/16Anti-alpha-synuclein antibodies and methods of use
04/21/16Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors
04/21/16Formulations with reduced oxidation
04/14/16Inhibitors of iap
04/14/16Cell culture media and methods of antibody production
04/14/16Anti-lgr5 antibodies and immunoconjugates
04/07/16Alkynyl alcohols and methods of use
04/07/16Anti-her2 antibodies and immunoconjugates
04/07/16Methods and compositions for detecting autoimmune disorders
03/31/16Azetidine estrogen receptor modulators and uses thereof
03/31/16Estrogen receptor modulators and uses thereof







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Genentech Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Genentech Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';